ECHO Connection

  • EDUCATION
    • EDUCATION BLOG
  • COLLABORATION
    • DOCTOR SIGNUP
  • HOPE
    • ECHO FAMILIES
    • APPLICATION
  • ABOUT
    • ORGANIZATION UPDATES
    • CONTACT
DONATEEuropean Donation

CBD Demonstrates Efficacy for Reducing Seizures in Children in First Clinical Trial

by ECHO / Tuesday, 06 June 2017 / Published in Education, Overview of Cannabinoids, Scientific Cannabinoid Research

A new landmark study investigating the efficacy of cannabidiol (CBD) for a rare form of childhood epilepsy shows the non-psychoactive cannabinoid is beneficial for reducing seizures. In the double-blind, placebo-controlled clinical trial, a team of researchers administered CBD to 120 children between the ages of two and 18 years diagnosed with Dravet syndrome for 14 weeks. The participants’ seizure frequency, which had remained resistant to traditional epilepsy treatments, dropped by an average of 39 percent with CBD.

“It’s a big landmark in the scientific study of [cannabidiol], and it’s a major landmark in epilepsy care,” said lead researcher Dr. Orrin Devinsky, neurologist at NYU Langone Medical Centre. “After four millennia of using [cannabinoids] to treat epilepsy, we now have for the first time scientifically rigorously obtained data that this specific compound works in this specific form of epilepsy.”

The average frequency of monthly convulsive seizures decreased from about 12 to about 6 with CBD. Three of the participants had their seizures stop entirely.

“Cannabidiol should not be viewed as a panacea for epilepsy, but for patients with especially severe forms who have not responded to numerous medications, these results provide hope that we may soon have another treatment option,” said Devinsky. “We still need more research, but this new trial provides more evidence than we have ever had of cannabidiol’s effectiveness as a medication for treatment-resistant epilepsy.”

More than nine of 10 of the participants did experience side effects, but those were generally reported as mild or moderate in severity. The most common side effects in those that took CBD were vomiting, fatigue and fever. Twelve of the children dropped out of the trial – nine in the CBD group and three from those taking the placebo.

“Side effects are always an issue, but the drug was tolerated about as well as conventional anti-epileptic drugs,” said Dr. Samuel Berkovic, director of the University of Melbourne’s Epilepsy Research Center in Australia.


You can learn more about CBD and its therapeutic effects on seizures by visiting our Education page. We also recommend these related articles:

  • Is CBD Legal?
  • How Does CBD Reduce Seizures? Here’s What Science Says
  • CBD Reduces Seizures in 84% of Children with Epilepsy, Study Finds

Stay up to-date with news from ECHO by following us on Facebook, Twitter, Instagram, and Pinterest.

Tagged under: CBD, Dravet Syndrome, Epilepsy, research

What you can read next

What Classifies Some CBD Products as Natural, While Others Are Organic?
Four Ways CBD Can Benefit You If You’re Over 50
CBD Has Antioxidant and Neuroprotective Properties. What Does That Mean?

Recent Posts

  • ECHO Announces Changes to Leadership

    We are making a few changes at ECHO Connection ...
  • Five States That Will Definitely Have Cannabis Legalization on the Ballot in November

    In any other year, cannabis legalization on the...
  • The Top Six CBD Podcasts to Listen to This Fall

    It’s no secret that the world is on a can...
  • Study Shows That Many CBD Beverages Contain Less or More Cannabidiol Than Advertised

    With CBD beverages increasing in popularity, it...
  • Beyond Ancestry—Cannabis DNA Tests Could Help You Find Your Ideal Strain

    By now, we’re all familiar with DNA test kits. ...

Receive the latest ECHO news by joining our newsletter.

  • Home
  • Education
  • Collaboration
  • Hope
  • ECHO Families
  • About
  • Blog
  • Contact

Privacy Policy   |   Terms of Use

Image credits: CMW Media

Notice: ECHO Connection is a 501(c)(3) non-profit organization, U.S. Federal Tax ID 81-4542024.  ECHO is also recognized as a charitable organization, Algemeen nut Beogende Instelling (ANBI) in the Netherlands, RSIN 8256 57 520.

2017 ECHO Connection™ - All Rights Reserved

TOP
ECHO Connection Website

The information contained in this website is for general information and educational purposes only. It does not constitute medical advice. Therefore, any reliance you place on such information is strictly at your own risk. Please check with your medical doctor before starting or changing your CBD routine.

By entering this site you agree to our TERMS OF SERVICE and PRIVACY POLICY.